CMRX
Chimerix Inc
NASDAQ: CMRX · HEALTHCARE · BIOTECHNOLOGY
$8.54
+0.00% today
Updated 2026-04-29
Market cap
$801.08M
P/E ratio
—
P/S ratio
3,778.70x
EPS (TTM)
$-0.99
Dividend yield
—
52W range
$0 – $0
Volume
1.4M
Chimerix Inc (CMRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.68M | $-26.28M | $-1.88M | $-25.56M | $-47.08M | $-99.89M | $-63.81M | $-50.13M | $-53.73M | $-75.18M | $-36.04M | $-99.93M | $-46.87M | $-69.09M | $-74.98M |
| Capital expenditures | $117000.00 | $321000.00 | $126000.00 | $193000.00 | $1.02M | $2.21M | $841000.00 | $151000.00 | $181000.00 | $158000.00 | $58000.00 | $207000.00 | $71000.00 | $89000.00 | $287000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $753000.00 | $1.05M | $1.40M | $3.07M | $4.41M | $12.96M | $16.22M | $16.11M | $13.07M | $9.53M | $5.57M | $12.26M | $15.29M | $17.46M | $9.48M |
| Free cash flow | $-21.80M | $-26.60M | $-2.00M | $-25.75M | $-48.09M | $-102.10M | $-64.66M | $-50.28M | $-53.91M | $-75.34M | $-36.10M | $-100.14M | $-46.94M | $-69.18M | $-75.26M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $90.07M | $18.49M | $-107.86M | $30.86M | $-32.91M | $62.56M | $-64.20M | $30.09M | $-31.59M | $10.45M | — | — |